Genetic approaches for targeted oxidative stress

Aninda Dey1,2, Ryan P Barnes1,2

  • 1Department of Cancer Biology, The University of Kansas Medical Center, Kansas City, Kansas, 66160, United States.

NAR Cancer
|December 25, 2025
PubMed

Insights

Cancer therapies using genetically engineered tools to produce reactive oxygen species (ROS) show promise. These light-activated photosensitizers target cancer cells, offering new avenues for oxidative stress-based treatments.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cancer cells exhibit altered metabolism, leading to excessive reactive oxygen species (ROS) and oxidative stress.
  • Tumors possess upregulated antioxidant defenses but remain vulnerable to further oxidative damage.
  • ROS can modify proteins, lipids, and nucleic acids, impairing cellular function.

Purpose of the Study:

  • To review genetic tools for targeted ROS production in cellular and organismal models.
  • To focus on tools offering spatial and temporal control over ROS generation.
  • To discuss the advantages and disadvantages of these tools for research and clinical applications.

Main Methods:

  • Genetic fusion of photosensitizers to target proteins.
  • Light-induced activation of photosensitizers to generate ROS.
  • Application in cellular and organismal models for studying ROS effects.

Main Results:

  • Development of genetically encoded tools for controlled ROS production.
  • Demonstration of ROS-induced protein inactivation, DNA damage, and cell ablation.
  • Evaluation of photosensitizer efficacy and specificity in different models.

Conclusions:

  • Genetically targeted ROS production offers a promising strategy for cancer therapy.
  • Photosensitizer-based approaches provide spatial and temporal control over oxidative stress.
  • These tools have significant potential for both basic research and translational applications in oncology.